Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Current seasonal influenza vaccines offer 'inadequate protection'


A new generation of more effective flu vaccines is “urgently needed” to prevent widespread illness and death, it has been claimed.

Scientists who analysed 40 years of data concluded that current vaccines offered inadequate protection against both seasonal influenza outbreaks and serious pandemics.

Evidence for their effectiveness in older individuals was also lacking, said the researchers who pooled the results of 31 studies published over four decades.

Overall, the most widely used seasonal flu vaccine, known as trivalent inactivated vaccine (TIV), was only 59% effective in healthy adults.

A newer kind of nasal spray vaccine containing a weakened “live” virus, LAIV (live attenuated influenza vaccine) was shown to prevent influenza in 83% of children aged seven or younger.

However, this type of vaccine is not currently recommended for children in the UK.

Dr Michael Osterholm, from the University of Minnesota in the US, one of the lead authors of the study published today in the journal The Lancet Infectious Diseases, said: “Evidence for consistent high-level protection is elusive for the present generation of vaccines, especially in individuals at risk of medical complications or those aged 65 years or older.

“The ongoing health burden caused by seasonal influenza and the potential global effect of a severe pandemic suggests an urgent need for a new generation of more highly effective and cross-protective vaccines that can be manufactured rapidly.

“In the meantime, we should maintain public support for present vaccines that are the best intervention available for seasonal influenza.”

The research showed that pandemic swine flu vaccine was around 69% effective in people aged under 65.

The scientists wrote: “This amount of protection is not adequate for a pandemic setting. The difference between 69% effectiveness and 90% effectiveness (or greater) will have a major public health effect in any pandemic that causes serious morbidity (illness) or increased mortality.”


Readers' comments (2)

  • I have been saying for ages that immunity to flu is not guaranteed with the flu vaccine, but my trust continue to tell staff that it is. Of course they don't want us to go off sick, but they are now saying that we have a duty of care to have the vaccine to protect our patients, colleagues and family. We do NOT have a duty of care to have the vaccine, and we have the same right as anyone else to make an informed choice about whether we want it or not. This article shows that the efficacy of the flu jab is not as good as we are all led to believe.

    Unsuitable or offensive? Report this comment

  • read this, above poster, some critical thinking rare in occ health depts it seems:

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs